PKD (Polycystic Kidney Disease) is becoming worldwide difficult-to-treat
disease and causing increasing death rate annually. Currently, doctors are
upping the ante in treatment of PKD. Why go under the scalpel if you can patch
your kidneys where they sit? The latest update therapy—Immunotherapy treatment
is surely making new breakthrough for sufferers of PKD.
What’s Immunotherapy?
Immunotherapy are immature and primary cells, which can be found in cord
blood, marrow and other sources. After extraction and cultivation, Immunotherapy
can differentiate into any type of human body cells. Due to its unique
properties of self-renewing and differentiation, it is successfully used in many
complex and difficult-to-treat diseases, such as diabetes, heart failure, cancer
and renal diseases, including Polycystic Kidney Disease (PKD).
How does Immunotherapy treat Polycystic Kidney Disease (PKD)?
Immunotherapy are used to repair impaired cells and tissues in the body
because they are far less likely than to be rejected than foreign cells that
originated from another source.
Normally speaking, if the regenerative processes in the kidneys can keep up
with the destructive, kidney damage caused by the growing kidney cysts that
ultimately lead tokidney failure, the kidneys can be maintain balanced and
kidney tissue can be preserved.
After implanted, Immunotherapy will arrive in body and hit the kidney and
then they are integrated into the existing tissue to repair damage. Because of
the plastic nature of Immunotherapy, they can potentially be used to repair the
damaged renal cells and tissues.
We have received more than 4000 cases of kidney diseases who adopted
Immunotherapy. Most of them got satisfactory effects and no major problems
happened in patients. Only some of them appear to have mild headache and stomach
which can be easily dealt with. So you need not worry much about its safety. If
you are interested or want similar cases, you can mail to kidney-treatment@hotmail.com
